So far in November 2026, GLP-1 drugs came up in 9 newsletters across 9 issues, up from 7 newsletters in October. Most coverage came from Kyle Westaway, The Markets Daily and Let's Buy a Biz!. The busiest day was Nov 7, with 3 mentions.
Get alerts when this topic surges in newsletters. Free to start.
Sign up free